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Translocations are chromosomal rearrangements that are frequently associated with a variety of disease states 
and developmental disorders. We identified 2 families with brachydactyly type E (BDE) resulting from dif-
ferent translocations affecting chromosome 12p. Both translocations caused downregulation of the parathy-
roid hormone-like hormone (PTHLH) gene by disrupting the cis-regulatory landscape. Using chromosome 
conformation capturing, we identified a regulator on chromosome 12q that interacts in cis with PTHLH over 
a 24.4-megabase distance and in trans with the sex-determining region Y-box 9 (SOX9) gene on chromosome 
17q. The element also harbored a long noncoding RNA (lncRNA). Silencing of the lncRNA, PTHLH, or SOX9 
revealed a feedback mechanism involving an expression-dependent network in humans. In the BDE patients, 
the human lncRNA was upregulated by the disrupted chromosomal association. Moreover, the lncRNA occu-
pancy at the PTHLH locus was reduced. Our results document what we believe to be a novel in cis– and in 
trans–acting DNA and lncRNA regulatory feedback element that is reciprocally regulated by coding genes. 
Furthermore, our findings provide a systematic and combinatorial view of how enhancers encoding lncRNAs 
may affect gene expression in normal development.
Introduction
Translocations are chromosomal rearrangements that can be inher-
ited and are often associated with cancers and congenital disorders. 
One of the great difficulties in determining mechanistic causes is 
the fact that translocations can affect gene expression and regula-
tory elements and alter chromosomal architecture by changing 
the relative genomic position of genes and their regulators. Thus, 
structural genomic changes may effect the regulatory landscape. 
Such perturbations may be involved in the well-known observa-
tions of position effects (1, 2). We combined several methods to 
resolve some of the complex translocation-related position effects 
on gene regulation, based on 2 families with brachydactyly type E 
(BDE). BDE is characterized by a shortening of metacarpals and 
metatarsals (3). The morphogenesis gene PTHLH, encoding para-
thyroid hormone–like hormone on chromosome 12p11.2, has been 
linked to BDE with short stature (4, 5). PTHLH is involved in the 
regulation of cartilage differentiation and digit condensation (6). 
During digit condensation, PTHLH and other factors act in concert 
to balance an intricate signaling network, ultimately impinging on 
BMP-mediated and sex-determining region Y-box 9–directed (SOX9-
directed) chondrogenesis (7). Dysregulated expressions of the hap-
loinsufficient genes PTHLH or SOX9 can cause skeletal phenotypes 
(2, 4, 5, 8–10). In previous work with a BDE family with balanced 
translocation t(8;12)(q13;p11.2), we discovered a breakpoint-depen-
dent PTHLH downregulation that elucidated new mechanisms 
resulting in a Mendelian phenotype (4). The cis regulation of gene 
expression is accompanied by distinct tissue- and cell type–specific 
histone modifications that enable or disable the binding of tran-
scription factors to evolutionarily highly conserved DNA elements 
(11, 12). cis-regulatory elements (CREs) can be intra- or intergenic 
(13, 14). They are typically located up to 1 megabase (Mb) from their 
coregulated genes (8, 15–17), but may be farther away. Enhancers 
may be transcribed into lncRNAs that increase gene expression 
in cis (18). Furthermore, lncRNAs can themselves act as enhancers; 
their expression is then correlated with the expression of associated 
genes (19). The lncRNA transcripts have more than 200 nt, display 
high interspecies conservation, and are multiexonic (20). Finally, 
lncRNAs are essential for the development of complex organisms 
(21). The most accepted model for CRE communication involves 
direct interaction of CRE with a gene promoter through spatial 
proximity in chromatin loops (22).
We here investigated another family with autosomal-dominant 
BDE and a balanced t(4;12)(q13.2-13.3;p11.2) translocation. The 
translocation-mediated genomic disruption of a CRE caused 
PTHLH repression and led to BDE in both translocation families. 
We studied the native PTHLH CREs and determined how they were 
altered. We discovered what we believe to be a novel CRE that acts 
both in cis and in trans. Within this CRE exists a lncRNA that was 
pivotal to its function. lncRNAs are known to be important to 
developmental programs and tumor suppressor gene networks (23). 
We observed reciprocal gene and lncRNA regulation that provide 
a systematic and combinatorial view of how enhancers encoding 
lncRNAs may affect gene expression in normal development. Dys-
function of the CRE and its lncRNA caused a Mendelian disease.
Results
Molecular characterization of t(4;12)(q13.2-13.3;p11.2). We analyzed 
a pedigree demonstrating autosomal-dominant inheritance. The 
roentgenograms were diagnostic of BDE (ref. 3, Figure 1A, and 
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Supplemental Figure 1, A and B; supplemental material avail-
able online with this article; doi:10.1172/JCI65508DS1). Affect-
ed individuals exhibited short stature (less than third percen-
tile). A relative shortening of the extremities in comparison to 
the trunk was evident. The arm span/height ratio was reduced 
(Supplemental Table 1). High-resolution karyotyping identified 
the balanced translocation t(4;12)(q13.2-13.3;p11.2) (Figure 1A). 
BDE-causative HOXD13 and PTHLH mutations were excluded by 
sequencing (5, 24). Breakpoint allele-specific sequencing identi-
fied the derivative chromosome 4 [der(4)] breakpoint 145,460 
bp downstream of PTHLH at position 28,147,744 bp (UCSC 
assembly hg18). The breakpoint was 45,433 bp downstream of 
the previously described der(8) breakpoint in t(8;12)(q13;p11.2) 
(4). Microdeletions and 7SL pseudogene insertions at the break-
points did not eliminate or create transcription factor binding 
sites (TFBSs; Supplemental Figure 1, E and F). To focus on the 
chondrogenic function of PTHLH, we induced chondrogenic dif-
ferentiation in fibroblasts of an affected patient and 2 nonaffect-
ed controls. Using quantitative RT-PCR, we observed downregula-
tion of PTHLH (P = 0.04) and its downstream targets, ADAMTS-7 
and ADAMTS-12 (Supplemental Figure 1, G and H). PTHLH was 
downregulated, and its insufficiency correlated with BDE in 
affected family members.
Identification of putative CREs for PTHLH and SOX9 by the 6C tech-
nique. Chromosome conformation capture (3C) techniques 
can identify gene-associated cis or trans regulators (25, 26). The 
3C method was extended to include ChIP, circularization, and 
cloning (6C technique). We purposely used a non–genome-wide 
approach to investigate the cis-regulatory landscape of the can-
didate gene PTHLH. The ChIP was done on chromatin of the 
chondrocyte cell line C28/I2 with anti-RNA polymerase II (rec-
ognized phosphorylated S5) and anti-H3K4me1 antibodies (27). 
We searched for H3K4me1-enriched CREs that were linked by 
chromatin loops to the active PTHLH or SOX9 promoters, our bait 
sequences. SOX9, located on chromosome 17 and expressed in 
C28/I2, is the major transcription factor commanding chondro-
genesis in the limb, known for long-range cis regulation (9, 28), and 
served as positive control. The intramolecular ultra-high dilution 
ligation resulted in circularized chromatin (29). Using inverse-
orientated oligos within the baits, we PCR amplified any CREs in 
the circular chromatin, subcloned the nested PCR amplicons, and 
sequenced the plasmids (Figure 1B).
We restrictively classified the reads: the bait sequence had to be 
adjacent to a CRE. These specific sequences of approximately 50 
nt of either the promoter or the promoter plus CRE were inter-
spersed by several nt due to the blunt-end repair of chromatin ends 
(Figure 1C). Randomly distributed positions at all chromosomes 
without the baits were classified as nonspecific. The 2% interac-
tion frequency of SOX9 reads identified 4 CREs on chromosome 
17, whereas 16.2% showed 9 CREs for PTHLH on chromosome 12 
(Figure 1D and Figure 2, A and B). The nonspecific sequences of 
92.6% in SOX9 6C compared with 47.9% in PTHLH 6C could be 
explained by the lower SOX9 expression observed (Figure 1E). Sur-
prisingly, we detected an interaction frequency of 1.4% in SOX9 6C 
for an in trans element on chromosome 12 (Figure 1D). The same 
element was also detected in PTHLH 6C (Figure 1C).
We then used ChIP to quantify the H3K4me1 and H3K4me2 
enrichment of the 6C-identified CREs by quantitative PCR 
(qPCR; Supplemental Figure 2 and ref. 30). To check for regula-
tory features of the putative 6C-identified CREs, we analyzed the 
interspecies PhastCons conservation, the ENCODE H3K4me1 
enrichment, and the ESPERR regulatory potential in UCSC. We 
performed comparative analysis of TFBSs on homologous DNA 
sequences from different species (rVISTA 2.0; zPicture) and iden-
tified highly conserved TFBSs (Supplemental Table 2 and Sup-
plemental Figures 3 and 4). SOX5, SOX9, PBX1, AP1, and HOXA 
motifs were among those detected. All are known to regulate 
limb bud development and chondrogenesis (reviewed in ref. 31). 
Based on significant H3K4me1 enrichment, the most abundantly 
found 6C interactions, and the in silico analysis, we selected 3 
CREs for further experiments: re70373 for SOX9 and re18527 and 
re52431 for PTHLH (Figure 2, A and B). re52431 on chromosome 
12q interacted with SOX9 in trans. Chromosomal aberrations (dup 
and del) in 3 patients with short stature and shortened phalan-
ges in the DECIPHER database of chromosomal imbalances and 
phenotypes (patient nos. 248901, 248785, and 250426) included 
the re52431 region, which indicates that the region is important 
during chondrogenesis.
Validation of the 6C results. New 6C libraries validated the reproduc-
ibility of the 6C technique. To determine bias, a human lympho-
blastoid cell line (LCL), marginally expressing SOX9 and PTHLH, 
was the control (Figure 1E). In a direct PCR approach, oligos were 
aligned in each of the 3 selected CREs and within the PTHLH or 
SOX9 promoter. We reproduced the chondrogenic in cis and in trans 
interactions (Figure 2C). In the LCL, re18527 did not interact, and 
re52431 showed a significantly lesser interaction by χ2 test, with 
PTHLH or SOX9. re70373 interacted with SOX9 in both cell lines, 
1.64 Mb more downstream than a previous reported CRE for 
SOX9 (9). The higher interaction frequencies in C28/I2 compared 
with those in LCL argued for the detection of chondrogenic-spe-
cific CREs. Due to the cis- and trans-chromosomal interactions of 
re52431, we termed this regulator CISTR-ACT.
The distances between the 6C-identified CREs and the associ-
ated gene promoter were far greater than previously reported (17). 
re70373 was 2.74 Mb downstream of SOX9. re18527 was 9.48 
Mb upstream, and CISTR-ACT 24.43 Mb downstream, of PTHLH 
(Figure 2D). We constructed luciferase reporters with the specific 
SOX9 and PTHLH promoter sequences downstream of re70373, 
re18527, and CISTR-ACT to investigate their enhancing poten-
tial. Since the latter were found combined with PTHLH in 6C, 
we constructed composite plasmids: CISTR-ACTF represented all 
identified TFBSs, whereas CISTR-ACTS was from the most con-
served part (Supplemental Figure 4). Significant enhancement 
of luciferase reporter activity for all CRE-PTHLH and CRE-SOX9 
constructs was observed. re70373 combined with CISTR-ACTS and 
CISTR-ACTF increased SOX9 promoter activity 2.5- and 3.8-fold, 
respectively (Figure 2E). CISTR-ACTS and CISTR-ACTF activated the 
PTHLH promoter less effectively than they did SOX9. The combi-
nation of re18527 with either CISTR-ACTS or CISTR-ACTF showed 
an additive activation effect on the PTHLH promoter (Figure 2F).
Physically detectable in cis or in trans interactions. To address spatial 
chromatin loops that might form between the selected CREs and 
the promoters as a prerequisite of gene regulation, we performed 
colocalization-FISH on C28/I2 nuclei (8). We captured 80 nuclei 
in each experiment and analyzed signal distances less than 1 μm. 
Bona fide colocalization signals merged below 0.27 μm (Mann-
Whitney rank-sum test; Figure 3A). For negative controls, we 
chose intervening probes between the gene and the CREs and 
equidistant loci from the CREs in the other direction on chromo-
some 12 or 17 (Supplemental Figure 5).
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Figure 1
The translocation t(4;12)(q13.2-13.3;p11.2) and scheme of the 6C method. (A) Translocation with der(4) and der(12). The hand roentgeno-
gram, especially the shortened metacarpals of digits 4 and 5, are diagnostic of BDE. (B) 6C. Formaldehyde-crosslinked chromatin of C28/I2 
chondrocytes was sonicated. After ChIP, the chromatin was blunt-end repaired and ligated at ultra-high dilution to favor intramolecular liga-
tion events. Chromatin loops were PCR amplified with inverse oligos, and the amplicons were subcloned and sequenced. PTHLH and SOX9 
promoters were the bait sequences. (C) Example of PTHLH 6C. Several bp were inserted due to the end repair of chromatin fragments. The 
interacting sequence was located at 52,431,496 bp on chromosome 12 (positions in bp; UCSC assembly hg18). In trans event in SOX9 6C. 
The interacting element on chromosome 12 was identified next to the bait sequence of the SOX9 promoter. (D) Restrictive classification of 
the 6C sequence reads. Either the promoter (bait) or the promoter interaction with any sequence was counted. (E) PTHLH and SOX9 mRNA 
expression in human C28/I2 and LCL.
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The measured distances between re18527 and PTHLH were 
significantly shorter than the negative controls (P = 9.31 × 10–3; 
Figure 3B and Supplemental Figure 5A). For investigation of the 
cis distance of 24.43 Mb between PTHLH and CISTR-ACT, probe 
pairs with accordant genomic distances on chromosome 15 
around the protein tyrosine phosphatase–like A domain contain-
ing 1 (PTPLAD1) locus were used as further controls. PTPLAD1 
was not expressed in C28/I2. Compared with all controls, CISTR-
ACT was in spatial proximity to PTHLH (Figure 3C and Supple-
mental Figure 5A). The colocalization of the re70373 element 
and SOX9 was barely significant; the intervening probe detected 
closer proximity (P = 0.028; Figure 3D and Supplemental Figure 
5B). The SOX9–CISTR-ACT in trans contact was compared with 
SOX9–chromosome 12q and SOX9–chromosome 15q probe pairs 
(Figure 3E). Moreover, 2 probe pairs of SOX9 with positions on 
the exterior nucleus–located chromosome 1 showed no spatial 
distance less than 1 μm. In all instances, CISTR-ACT had sig-
nificant contact with SOX9. Putative chromosome 12 with 17 
translocations were excluded in metaphase FISH (Supplemental 
Figure 5C). The statistical analysis showed undetermined signal 
distances, but specific cis or trans interactions of CISTR-ACT with 
PTHLH or SOX9 happened in a fraction of cells. The frequency 
distributions of colocalized or very close signals were significant-
ly higher in the experimental measurements than in the negative 
Figure 2
6C results and validation. (A and B) Interaction frequencies of SOX9 (A) and PTHLH (B) 6C data. In SOX9 6C, 4 CREs were detected; 9 were 
found in PTHLH 6C (black symbols). re70373, re18527, and re52431 were the most abundant, and further characterized by high mammalian 
conservation, H3K4me1 enrichment (ENCODE), and ESPERR regulatory potential (denoted by “+”) (positions in bp; UCSC assembly hg18). 
re52431 interacted with SOX9 in trans. (C) New 6C libraries validated prior 6C results; control was a LCL. A direct PCR approach amplified 
re70373, re18527, and re52431. In the LCL, the C28/I2 CRE interactions were significantly reduced; only for re70373 were interactions in C28/
I2 and LCL detected equally. (D) Distances of cis- and trans-regulatory elements identified in PTHLH 6C and SOX9 6C. re18527 (18,527,200 bp) 
and re52431 (52,431,500 bp) interacted with PTHLH, re70373 (70,373,400 bp) interacted in cis and re52431 in trans with SOX9. re52431 was 
further named CISTR-ACT, due to its cis and trans interactions. (E) Luciferase reporter assays of re70373, CISTR-ACTF (full-length regulatory 
sequence), and CISTR-ACTS (containing the most conserved part) elements were placed in front of the SOX9 promoter; all 3 enhanced tran-
scription. (F) re18527, CISTR-ACTF, and CISTR-ACTS, either alone or in combination, controlled the PTHLH promoter and enhanced luciferase 
transcription (n = 6). ***P ≤ 0.001; **P ≤ 0.01; *P ≤ 0.05.
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controls (Table 1). Overall, the in cis genomic distances between 
promoter and CRE were inversely proportional to the interaction 
frequencies in cells. Consistent with the 6C results, the FISH data 
excluded the possibility that incidental intrachromosomal fold-
ing or interchromosomal territorial contacts occurred.
CISTR-ACT expresses the lncRNA DA125942. Interestingly, we 
found an expressed sequence tag, DA125942, with 2 exons over-
lapping with CISTR-ACT on 12q in the UCSC Genome Browser. 
DA125942 represented a nonpolyadenylated lncRNA of 581 bp 
(Supplemental Figure 4). Rapid amplification of cDNA ends 
(RACE) experiments confirmed the full-length transcript in C28/
I2 cells. To determine whether DA125942 transcription was inde-
pendent of an external promoter and regulator, we constructed a 
vector lacking regulatory sequences (pGL-luci) and added re18527, 
CISTR-ACTS, or CISTR-ACTF alone or in combination. Using quan-
titative RT-PCR, we observed highly upregulated DA125942 in 
C28/I2 cells transfected with CISTR-ACTF (Figure 4A). This result 
was suggestive of 2 concepts: first, CISTR-ACTF harbors an inter-
nal promoter driving the transcription; and sec-
ond, mature DA125942 results from splicing. Kim 
and colleagues reported similar observations (18). 
In disrupted CISTR-ACTS plasmids, DA125942 was 
not expressed, and re18527 negatively influenced 
DA125942 expression (Figure 4A).
lncRNAs can enhance and specifically influence 
gene regulation in cis over several Mb (19). We pro-
posed that DA125942 could conduct in cis regula-
tion of PTHLH expression and simultaneously 
could also be involved in the in trans regulation of 
SOX9. To test this issue, we used siRNA knockdown 
in C28/I2 cells to deplete DA125942, PTHLH, and 
SOX9. Depletion of DA125942 resulted in downreg-
ulation of PTHLH and SOX9. Surprisingly, knock-
ing down PTHLH and SOX9 significantly increased 
DA125942 expression by 4- and 6.8-fold, respective-
ly, suggestive of reverse action of these gene prod-
ucts on lncRNA transcription. Silencing of SOX9 
led to significantly reduced PTHLH expression, 
and vice versa (Figure 4B). These results implied 
an interactive influence of DA125942, PTHLH, and 
SOX9 on transcript levels. Overexpression of PTHLH 
or SOX9 led to upregulation of DA125942, SOX9, or 
PTHLH. DA125942 overexpression repressed the 
expression of the coding genes (Figure 4C). These data confirmed 
the expression dependency of the network.
The HOXC cluster is localized 187 kb downstream of DA125942, 
and several lncRNAs are encoded by, and interact with, HOX 
loci (32, 33). We tested whether DA125942 regulated HOXC or 
other genes either in cis or in trans by 3′ expression profiling. We 
overexpressed and depleted DA125942 in C28/I2 cells. The com-
bined ANOVA resulted in 1,842 differentially expressed probes (5% 
false discovery rate [FDR]; Supplemental Table 4). To distinguish 
up- and downregulation patterns, k-means clustering was per-
formed (Supplemental Figure 6A). Chromatin-remodeling genes, 
i.e., protein arginine methyltransferase 1 (PRMT1), high mobility 
group nucleosomal binding domain 2 (HMGN2), polycomb group 
ring-finger 6 (PCGF6), and enhancer of zeste homolog 2 (EZH2), 
and several transcription factors were differentially expressed in 
clusters 1, 3, 4, and 5 (Supplemental Figure 6B). In cluster 2, 33 
genes had annotations linking them to organ morphogenesis 
(GO:0009887; P = 7.51 × 10–7); 11 genes as singletons were excluded 
Figure 3
Colocalization-FISH. (A) Examples of colocalized 
vs. separate signal pairs in C28/I2 nuclei (distances 
in μm; scale bars: 2 μm). (B) Accumulated colocal-
ized signals were found in all experiments. Shown 
are genomic distances between probes (in Mb); 
Mann-Whitney test was used to determine signifi-
cance. PTHLH was in physical proximity to re18527 
compared with the re18527 negative control, with 
a 9.5-Mb equidistant upstream probe 12p(1). (C) 
CISTR-ACT significantly showed interaction with 
PTHLH compared with the 3 controls. PTPLAD1 was 
not expressed in C28/I2. (D) re70373 was marginally 
in spatial proximity to SOX9. (E) Significant in trans 
actions of CISTR-ACT with SOX9. In the control of 
SOX9 with a chromosome 15q(1) probe, only 2 signal 
pairs had distances less than 1 μm.
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in STRING network (Figure 4D). In addition to PTHLH and SOX9, 
we found essential morphogenesis genes for early limb patterning 
and chondrogenesis. Hypoxia inducible factor 1 (HIF1A) regulates 
SOX9 (34). Noggin (NOG) and follistatin (FST) regulate outgrowth 
and chondrogenesis in the chicken limb bud (35, 36). ETS variant 
4 (ETV4) is involved in limb outgrowth and in the anterior-pos-
terior patterning of the autopode (37). The HOXB genes HOXB3, 
HOXB5–HOXB7, and HOXB8 (singleton; data not shown) and the 
HOXC genes code for transcription factors involved in diverse mor-
phogenetic processes, including limb formation (38, 39). None 
of the HOXC genes was differentially expressed. Osteoprotegerin 
(TNFRSF11B) and the vitamin D receptor (VDR) maintain mineral 
bone density in osteoblasts (40). The HOXB cluster, ETV4, NOG, 
and SOX9 were all located on chromosome 17, indicative of several 
DA125942-mediated gene regulations.
DA125942 in BDE patients and its binding at the PTHLH and SOX9 
loci. We investigated whether the 2 independent translocations 
on 12p influenced, next to the PTHLH downregulation, the dis-
tant DA125942 and SOX9 expressions in BDE patients. Significant 
DA125942 upregulation in chondrogenically differentiated fibro-
blasts of BDE patients with t(8;12) or t(4;12) was found (Figure 4, 
E and F). SOX9 was marginally, but not significantly, downregulat-
ed (P = 0.059; Supplemental Figure 7A). Next, we addressed wheth-
er DA125942 occupied the PTHLH and SOX9 loci and whether the 
interaction was altered in the translocations t(8;12) and t(4;12). We 
used the recently described chromatin isolation by RNA purifica-
tion (ChIRP) method with split probe sets 1 and 2, tiling DA125942 
(∼80% tiled) on chromatin of C28/I2 and chondrogenically differ-
entiated BDE fibroblasts (41). For qPCR, we eluted RNA to mea-
sure lncRNA enrichment and DNA to detect DA125942 occupancy 
at the PTHLH or SOX9 loci; approximately 12 kb of each gene was 
analyzed. A probe set against lacZ, the GAPDH and CISTR-ACT loci, 
and a healthy proband served as controls; nonprecipitated RNA 
or chromatin was the input control. DA125942 was 1- to 5.6-fold 
enriched compared with the input. As expected, in chromatin from 
BDE patients, more lncRNA was retrieved; GAPDH and lacZ were 
not detected (Figure 4G). Since the lncRNA occupancy at genomic 
loci is not well understood, we analyzed low and highly conserved, 
intronic, exonic, and promoter sequences especially in regions of 
ENCODE-annotated TFBSs. We detected DA125942 
binding in the eluted C28/I2 DNA at the PTHLH and 
SOX9 loci (Figure 4, H and I). In qPCR of the restricted 
chromatin from BDE patients, we analyzed the high-
est and lowest enriched positions that we had found 
in C28/I2 cells. Compared with the healthy proband, 
binding of DA125942 at the PTHLH locus was signifi-
cantly reduced in the BDE patients’ chromatin (Figure 
4J). Binding at the SOX9 locus was not significantly 
altered (Figure 4K); the GAPDH or DA125942 loci were 
not detected (Supplemental Figure 7, B and C).
CISTR-ACT is an evolutionarily conserved mechanism. 
The homologous regions to the human CISTR-ACT 
in mouse and in rat were detected on the basis of the 
DNA sequence, including 1-exon lncRNA transcripts 
in both species (mouse, AW491522; rat, BM385392). 
By phylogenetic and comparative analysis of TFBSs 
by Mulan (42, 43), we found that 121 multiconserved 
TFBSs overlapped in humans, mice, and rats. The 
lncRNA sequences were evolutionarily more divergent 
(Figure 5, A and B). In contrast to the human genome, 
the lncRNAs AW491522 and BM385392 were not located on the 
chromosome encoding Pthlh (Figure 5C), raising the possibility of 
solely in trans–acting regulation. The approved mouse ATDC5 cells 
and rat chondrocytes (RCSs) were used to study chondrogenesis 
(44, 45). ATDC5 cells were chondrogenically differentiated for 10 
days to induce major chondrogenic markers (Supplemental Figure 
8, A and B). We again used siRNA transfections to knock down 
Pthlh, Sox9, and each lncRNA to investigate whether there is an 
expression-associated mechanism corresponding with that found 
in humans. AW491522 or BM385392 knockdown led to Pthlh and 
Sox9 downregulation. In contrast to the observations in human 
C28/I2 cells, Pthlh or Sox9 depletion caused lncRNA downregula-
tion in ATDC5 cells and RCSs (Figure 5, D and E), indicative of 
an evolutionarily more complex gene regulation in humans. By 
ChIRP experiments with 2 probe sets targeting the homologous 
regions of the rodent lncRNAs (∼80% tiled), we retrieved approxi-
mately 60% (Figure 6A). In qPCRs on eluted DNA, homologous 
regions at the rodent Pthlh or Sox9 loci were occupied by either 
AW491522 or BM385392 (Figure 6, B–E). The regions corresponded 
to the human regions occupied by DA125942; enrichment of the 
lncRNA loci and Gapdh was not detected (Supplemental Figure 8, 
C–F). Further investigation is required to determine whether the 
exposed CISTR-ACT locations on the outer chromosomal q arms 
support the trans regulations. Overall, these data indicate that the 
lncRNAs act in a contact-based manner and that the network is 
conserved among the mammals studied herein.
CISTR-ACT shows mesenchymal and prechondrogenic involvement in 
transgenic embryos. To investigate whether the human and mouse 
CISTR-ACTs act as classical enhancers in the developing limb 
buds, we generated transgenic embryos using pronuclei microin-
jection. The CISTR-ACTs were cloned in front of a lacZ reporter. 
All stages analyzed showed consistent lacZ expression patterns 
during limb development. Human transgene-driven lacZ expres-
sion was detected in the distal limb bud mesenchyme at E10.5 
and E11.5, with a recognizable shift toward the anterior part (Fig-
ure 7A). At E12.5, lacZ was expressed overlapping with condensa-
tions of digits 1, 2 and 4 and in the first and fourth interdigital 
mesenchyme (Figure 7A). At E13.5, the strongest expression was 
maintained overlapping with the condensations of digits 1 and 2 
Table 1
Statistical analysis of colocalization-FISH on C28/I2 nuclei
Probe pair Distance CI Signals Signals 
 (mean ± SD)  <1 μm (%) <0.27 μm (%)
re18527/PTHLH 0.61 ± 0.25 0.57–0.65 54.3 34.5
12p(1)/re18527 0.71 ± 0.22 0.65–0.76 26.9 0
PTHLH/CISTR-ACT 0.52 ± 0.32 0.44–0.61 20.3 12.9
CISTR-ACT/12q(1) 0.75 ± 0.17 0.67–0.83 9.9 0
PTPLAD1/15q(1) 0.81 ± 0.19 0.70–0.92 6.7 0
15q(2)/PTPLAD1 0.83 ± 0.13 0.77–0.86 10.5 0
SOX9/re70373 0.62 ± 0.24 0.57–0.68 46.3 9.5
re70373/17q(2) 0.71 ± 0.19 0.66–0.75 27.5 1.3
SOX9/CISTR-ACT 0.33 ± 0.23 0.24–0.43 25.0 72
SOX9/12q(1) 0.62 ± 0.12 0.50–0.75 3.1 0
SOX9/15q(1) n.a. n.a. 0 0
80 nuclei were captured in each experiment, and signal distances <1 μm were mea-
sured. In all instances, the regulators were significantly associated with their respective 
promoters, compared to controls. CI, confidence interval; n.a., not available due to 
distances >1 μm.
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and the first interdigit. Weaker staining was visible overlapping 
the condensations of digit 3 and the distal tip of digit 4 as well as 
in interdigits 2, 3, and 4. Thus, lacZ expression overlapped with 
domains known to be involved in skeletal patterning, as well as 
those undergoing and/or regulating chondrogenesis (46). Mouse 
transgene-driven lacZ expression analyzed at E10.5 and E12.5 
showed a strong overlap with the staining of the human counter-
parts in both cases. At E12.5, staining from the mouse transgene 
showed restriction to the first interdigit and regions overlapping 
condensations of digits 1 and 2. The domains, in part, correlated 
with previous documentation of the early limb patterning and 
chondrogenesis genes identified in our expression profiling, 
including Hoxb8, Etv4, Pthlh, and Sox9 (37, 47–49).
These results showed that the translocation-mediated disruption 
of the PTHLH–CISTR-ACT chromosomal association affected the 
chromosomes’ feedback control and caused PTHLH and DA125942 
dysregulation. The findings in the BDE patients were analogous 
to those from the in vitro and in vivo studies described herein and 
expand our knowledge about remote-controlled gene and lncRNA 
regulation in altered chromatin architecture (Figure 7, B and C).
Discussion
Our results elucidate how the translocation-mediated disruption 
of the PTHLH–CISTR-ACT association caused disease and shed 
light on the complexity of a molecular pathogenic mechanism that 
we believe to be novel. These basic chromatin-related epigenetic 
findings could be of great translational value, especially in other 
diseases with chromosomal rearrangements. We demonstrated 
consistent results in patient material and in both in vitro and 
in vivo models. We documented that chromatin loops involving 
conserved DNA elements and lncRNA existed for intra- and inter-
chromosomal communication, resulting in the regulation of gene 
and lncRNA expression. We elucidated CISTR-ACT to be a chon-
drogenic regulator, encoding lncRNA.
The human CISTR-ACT pinpointed SOX9 in trans on chromo-
some 17. We observed spatial nuclear proximity of the cis elements 
with distances of 9.48 and 24.43 Mb to PTHLH with colocaliza-
tion-FISH. Proximal CRE promoter signals occurred. These tem-
porary interactions happened in a limited number of cells, which 
indicates that adequate target gene expression and maintenance 
of tissue specificity were effectively fulfilled. In studies of a human 
ectopic β-globin locus control region (LCR), similar observations 
were made. Rare ultra-long range regulations and endogenous 
trans β-globin activation happened only in “jackpot” cells with 
enriched interchromosomal interaction (50). Amano and col-
leagues studied murine limbs and observed that sonic hedgehog 
(Shh) cis regulation was only active in some fractions within the 
area of Shh expression, but not in others. These findings confirm 
that chromatin looping is also tissue and developmental stage 
specific (51). Based on our observations using FISH and 6C, we 
suggest that tissue-specific fine regulation mediated by chromatin 
loops occurs infrequently and unpredictably.
We characterized the function of the CISTR-ACT–encoded 
lncRNAs in siRNA and overexpression experiments. We recapit-
ulated the expression-associated network in 3 species. lncRNA 
silencing led to PTHLH or SOX9 repressions in humans and 
rodents, whereas their altered expression coincided with lncRNA 
dysregulation. Some lncRNAs have enhancer-like functions and 
are associated with gene expression (19). In contrast to this prior 
report, we here present evidence for a regulatory feedback expres-
sion network. Coding genes could regulate lncRNAs, and vice versa 
(Figure 7B). lncRNAs may be necessary to establish transcription 
by recruiting secondary mediators, as previously shown for the epi-
genetic state regulation of rRNA genes (52). In ChIRP experiments, 
we documented that the lncRNAs bound at the PTHLH and SOX9 
loci. This finding indicates that the lncRNAs act directly on the 
coding genes’ loci. The translocation-altered chromatin architec-
ture seemed to suppress the looping of CISTR-ACT necessary to 
find and adequately regulate PTHLH by its lncRNA or vice versa. 
PTHLH has a nonclassical nuclear localization signal and can bind 
RNA in the nucleus (53, 54).
Wang and colleagues observed that the long intergenic ncRNA 
(lincRNA) HOTTIP activates several HOXA genes by proximity and 
bound protein mediators, thereby maintaining active chromatin. 
Ectopic HOTTIP did not regulate HOXA genes in their study and 
generated a dominant-negative effect (33). Supported by their 
findings, we believe that regular chromosomal contacts bring the 
CISTR-ACT DNA locus in proximity of its target genes to bring 
down its lncRNA as an intermediate for targeting the regulated 
coding genes. Hence, the translocation-mediated altered chromo-
somal architecture disrupted the chromatin looping and the abil-
ity of CISTR-ACT’s lncRNA to find PTHLH. Moreover, DA125942 
overexpression led to PTHLH and SOX9 repression. The lncRNA’s 
overexpression may lead to the binding of proteins that can gener-
ate a dominant-negative effect, as the repressed PTHLH leading to 
autosomal-dominant BDE.
lincRNAs interact with chromatin-remodeling complexes in a 
well-documented manner for HOTAIR at the HOXC gene cluster 
and XIST for the X chromosome inactivation (32, 55, 56). Chro-
matin-remodeling genes and ncRNAs determine tissue-specific 
epigenetic states and gene expression (57). In studies of HOTAIR 
or XIST ncRNA, others have proposed that lncRNAs mediate 
genetic traffic to establish specific epigenetic marks, resulting in 
guided gene expression (58). The differentially expressed genes 
Figure 4
DA125942 transcription and dependent regulation of SOX9, 
DA125942, and PTHLH. (A) CISTR-ACTS and CISTR-ACTF, with 
or without re18527, were cloned in a promoter and regulator lack-
ing plasmid (pGl2-luci). In CISTR-ACTF–transfected C28/I2 cells, 
DA125942 was highly expressed. re18527 blocked the transcription; 
CISTR-ACTS produced no transcription. (B) SOX9 expression was 
knocked down relative to the scrambled siRNA control. Depleted 
PTHLH or DA125942 downregulated SOX9. siRNA-mediated deple-
tion of PTHLH and SOX9 upregulated DA125942, and PTHLH 
expression was significantly reduced by PTHLH, DA125942, and 
SOX9 siRNA (n = 6). (C) Overexpression of PTHLH, SOX9, and 
DA125942 confirmed the expression-dependent network (n = 4). (D) 
STRING network. Expression array analysis revealed 22 organ mor-
phogenesis genes (GO:0009887) showing interactions. Line thick-
ness is indicative of physical or functional interaction confidence. 
Mesenchymal and prechondrogenic genes were differentially regulat-
ed. (E and F) Fibroblasts of affected BDE patients (AFF) and 3 non-
affected subjects (NON) were chondrogenically induced. DA125942 
was upregulated in patients of both BDE families (n = 3). (G) RNA-
ChIRP on C28/I2, nonaffected subject, and BDE patient chromatin. 
DA125942 was retrieved in contrast to GAPDH. (H and I) ChIRP on 
eluted C28/I2 DNA detected DA125942 binding at the PTHLH and 
SOX9 loci. Each amplicon was mapped by the UCSC custom tracks 
(numbered black boxes). (J and K) In t(4;12) and t(8;12), reduced 
lncRNA occupancy at the PTHLH locus was observed; binding at 
SOX9 was not affected (n = 2). ***P ≤ 0.001; **P ≤ 0.01; *P ≤ 0.05.
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suggest that DA125942 has several functions. The preparation of 
transcriptionally active euchromatin through the lncRNA might 
go hand in hand with specific morphogene regulation, medi-
ated by the lncRNA and by DNA- or RNA-bound factors. The 
underlying highly conserved CISTR-ACT DNA sequences, with 
the predicted chondrogenic TFBSs, showed tissue-specific regu-
lation in the transgenic embryos. The CISTR-ACT–driven lacZ 
expression domains partially overlapped with the expression 
patterns of Hoxb8, Etv4, Pthlh, and Sox9. These morphogenesis 
genes were also differentially expressed in expression profiling. 
Moreover, the domains anatomically covered the most apparent 
human BDE regions.
Translocation-mediated chromosome 12 disruption led to 
the dysregulation of PTHLH and DA125942. The zinc-finger 
protein CTCF is the best-described regulator mediating either 
intra- or interchromosomal genome organization (59, 60). 
Aberrant genomic architecture results in disorganization and 
failed recruitment of secondary mediators to genomic loca-
tions. Thus, the tissue-specific feedback expression of PTHLH 
and DA125942 does not occur. We suggest that SOX9 and 
PTHLH share common sites of transcription and belong to a 
chondrogenic transcription factory (61, 62). As far as we know 
from studying chromosomal aberration syndromes and intact 
chromosomes, certain chromosomal territories must be main-
tained to ensure proper gene regulation (63, 64). In a 3D map 
of human fibroblasts, the chromosome 12 and 17 territories are 
adjacent, although unambiguous deterministic chromosomal 
neighborhoods are not observed (65). We hypothesize that the 
trans-mediated regulation of SOX9 can occur because the major 
der(12)s carrying CISTR-ACT remain in their chromosomal ter-
ritory. CISTR-ACT is still able to communicate with SOX9 on 
17q, although the PTHLH and lncRNA dysregulations mar-
ginally affect SOX9 expression. PTHLH on 12p appears to be 
translocated to the chromosomal territories of chromosomes 4 
and 8, respectively. Access to the CISTR-ACT is prevented by the 
translocation (Figure 7C).
Taken together, these observations broaden our awareness of 
regulatory distances across the centromere, further elucidate 
the incidence of trans-regulatory DNA-DNA and RNA-lncRNA 
communication, and suggest that molecular dysfunctions that 
result in clinical phenotypes are highly complex. We provided 
genetic evidence that chromosomal communicators work syn-
ergistically at both the DNA and RNA levels in a combinatorial 
and responsive fashion. The reciprocal fine regulation of gene 
and lncRNA expression is a systems biological process, account-
ing for effective development or tissue perpetuation. We believe 
that nucleus-based networks probably serve to maintain tempo-
rary, consecutive, and tissue-specific expression of certain gene 
products. The recruitment mechanism supporting the locus-
specific contact must be investigated further. We argue that bio-
physical and biochemical processes work together stochastically 
and dynamically. Chromosomes own their territories; although 
mitotic and meiotic conformational changes occur, they are 
not randomly organized. Nuclear organization is evolutionarily 
conserved and directed (64, 66). Brownian motion, directed bio-
chemical mechanisms, and effects that can be described using 
chaos theory could regulate the diverse interactions (67). We 
propose that determination meets variability.
Figure 5
CISTR-ACT in rodents. (A and B) Phylogenetic analysis of the CISTR-ACT DNA and lncRNA sequences. 121 conserved TFBSs were bioinformati-
cally predicted. The differences of the scales indicate that the lncRNAs are evolutionarily more divergent than the conserved DNA sequences. (C) 
Genomic arrangement of murine and rat Pthlh, Sox9, and CISTR-ACT–encoded lncRNAs AW491522 and BM385392, respectively, suggested 
an in trans network. (D) siRNA transfections of mouse ATDC5 (10 days differentiated) chondrocytes. Depletion of the mouse lncRNA AW491522 
caused Pthlh or Sox9 downregulation. Knockdown of either Pthlh or Sox9 depleted the lncRNA (n = 4). (E) siRNA assays in RCSs. An analogous 
expression-dependent network was observed compared with the ATDC5 results (n = 5).**P ≤ 0.01.
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fibroblasts was done as previously reported (4); ITS-X (Life Technologies) 
induced ATDC5 chondrogenic differentiation.
Metaphase FISH and colocalization-FISH. Metaphase FISH analysis was 
performed using standard protocols. BACs and fosmids were ordered at 
RZPD (www.imagenes-bio.de). 2D colocalization-FISH was performed 
as previously reported (69). The Olympus-BX61 microscope with 
U-TV1X2 and PlanApo 60×/1.4 oil lens in combination with the ASI 
CCD-camera 1300QDS and FISHView software (version 6.0.0.18) were 
Methods
Patients. After obtaining written informed consent, we studied 2 affected 
(III:1 and III:4) and 2 nonaffected (III:3 and IV:1) individuals. Skin fibro-
blasts from 1 affected individual (III:4) were obtained.
Cell culture. Fibroblasts were cultured in MEM 199, C28/I2 and ATDC5 
cells were cultured in DMEM/F12 at a 1:1 ratio (68), and RCSs were cul-
tured in DMEM; all were supplemented with 10% FCS, 100 U/ml peni-
cillin, and 100 μg/ml streptomycin. The chondrogenic differentiation of 
Figure 6
ChIRP on ATDC5 and RCS chromatin. (A) AW491522 and BM385392 retrieval. Mouse or rat Gapdh was not precipitated. (B and C) ChIRP on 
eluted DNA detected AW491522 binding at the murine Pthlh (B) and Sox9 (C) loci. Each amplicon was mapped by the UCSC custom tracks 
(numbered black boxes). (D and E) BM385392 binding at the rat Pthlh (D) and Sox9 (E) loci. The lncRNA’s occupancy was observed at homolo-
gous regions in mouse and rat (red shading). Annotated mammalian conservation is shown; genomic positions correspond to mouse assembly 
mm9 and rat assembly rn4 (n = 2).
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siRNA-1 antisense, UUUGCUCUGACCAGAUCUCTA; siRNA-2 sense, 
CAAUACUUCUGGACUCUCUTT; siRNA-2 antisense, AGAGAGUC-
CAGAAGUAUUGCA. Negative control was scrambled siRNA. SOX9, 
DA125942, and PTHLH were significantly downregulated (>75%). The 
siRNA for GAPDH was a reference for transfection efficiency and down-
regulation. Overexpression transfections were done as previously described 
by Fugene X-tremeGENE HP (Roche). PTHLH (SC307833) and SOX9 
(SC321884) expression plasmids were obtained from OriGene.
Bioinformatics and 3′ expression array analysis. Genomic sequences were 
analyzed by NCBI BLAST, UCSC BLAT, repeat masking at GIRI Institute, 
and in the UCSC Genome Browser (March 2006; NCBI36/hg18) (70, 71). 
rVISTA version 2.0 and Transfac Professional version 10.2 were used to 
determine mammalian conserved TFBSs (72, 73). Functional experiments 
were done at least 3 times. Number of experiments (n) are shown in figure 
legends. Significance was determined by Student’s t test. Signal detections 
in colocalization-FISH were statistically analyzed by Mann-Whitney rank-
sum test; data represent mean ± SD. Expression profiling was done on ht12 
arrays (Illumina) in biological triplicates, followed by ANOVA, multiple 
testing (FDR 5%), cluster, GProfiler enrichment, and STRING analysis. The 
microarray dataset was deposited in GEO (accession no. GSE39896; http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39896).
On the BeadStudio 1.0.2.20706 Platform array, data were quantile nor-
malized at the probe level without background correction, and consistently 
low-expressed transcripts (minimum detection P > 0.05) were rejected. Data 
were log2 transformed after an offset addition (16) and analyzed on sig-
nificant expression differences among the 4 groups (siRNA-depleted and 
overexpressed DA125942 C28/I2 RNA, controls with empty expression vec-
tor, and scrambled siRNA) in triplicate using ANOVA followed by a FDR 
(74) multiple testing correction. Probes that underwent 5% FDR were 
used for signal detection and measurements. Measurements were made 
independently by 2 different investigators.
6C and ChIRP. See Supplemental Methods for the detailed 6C protocol. 
ChIRP was done according to a previously published protocol (41); see 
Supplemental Table 5 for probes.
Reporter assay, siRNA knockdown, and expression plasmids. 5 × 104 cells were 
seeded 12–24 hours prior to transfection. Equal molarities in transiently 
transfected C28/I2 cells compensated for the diverse plasmid sizes. For 
reporter assays, 75 fmol each of the CRE promoter luciferase constructs 
were transfected with Fugene HD according to the manufacturer’s recom-
mendations (Roche). The SOX9 promoter sequence was on chromosome 
17: 67,626,313–67,629,147 bp (UCSC assembly hg18). The vector back-
bone was pGL2-basic (Promega); 12.5 ng pRL-TK (Promega) was added to 
control transfection efficiency. Lysates were analyzed using the Dual-Glo 
Assay (Promega). 100 nM siRNA were transfected with Dharmafect (Dhar-
macon) for 48 hours in C28/I2 and ATDC5 cells, 120 nM siRNA were used 
for RCS transfections. Scrambled, GAPDH, SOX9, and PTHLH siRNAs were 
validated (Ambion). Different custom-designed siRNAs for the lncRNAs 
were obtained. For visual simplicity, results using only 1 siRNA are shown.
DA125942 siRNAs were as follows: siRNA-1 sense, GCACAUGAC-
CACAUGGAAATT; siRNA-1 antisense, UUUCCAUGUGGUCAU-
GUGCGA; siRNA-2 sense, GUUUCUCUCAGCAAAUUCATT; siRNA-2 
antisense, UGAAUUUGCUGAGAGAAACTG; siRNA-3 sense, CAAGGA-
CACUGAAAAAGCUTT; siRNA-3 antisense, AGCUUUUUCAGU-
GUCCUUGAG. AW491522 siRNAs were as follows: siRNA-1 sense, 
AGGCCCUGAUGCUAGUGAATT; siRNA-1 antisense, UUCACUAG-
CAUCAGGGCCUTG; siRNA-2 sense, GCACGCAUCUCUUCCACCATT; 
siRNA-2 antisense, UGGUAAGAGAUGCGUGCGG. BM385392 siR-
NAs were as follows: siRNA-1 sense, GAGAUCUGGUCAGAGCAAATT; 
Figure 7
Transgenic embryos expressing the human and mouse CISTR-ACT–lacZ constructs. (A) E10.5, E11.5, E12.5, and E13.5 embryos showed 
consistent lacZ expression patterns during limb bud development. fl, fore limb; hl, hind limb; d, digit; id, interdigit. Scale bars: 1 mm. (B) Results 
of siRNA and overexpression experiments elucidated a reciprocal expression-associated network. T-bars denote downregulation of expression; 
arrows denote upregulating effects. (C) Scheme of the cis-regulatory network between PTHLH on chromosome 12p and the CISTR-ACT locus 
with its lncRNA DA125942 on 12q. Translocations altered the chromosome 12 territory (right), leading to dysregulation of PTHLH and the lncRNA. 
Orange denotes translocated chromosomal arms.
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k means clustered with average Euclidean distance function and k = 5, 
according to a local minimum in the Davies-Bouldin k estimation (75). 
Clusters 1, 2, and 4 were selected according to those outstanding expres-
sion statuses in DA125942 silencing and further investigated by functional 
enrichment and interaction. Enrichment analysis was performed using 
G:Profiler (76), with a simulation-based analytical threshold for signifi-
cance estimation. Physical and functional interactions between proteins 
were determined using the String platform (77) and a medium confidence 
score of 0.4. Resulting singletons were rejected before network visualization.
Transgenic mice. Human (chromosome 12; 52,430,503–52,431,992 bp; 
assembly hg18) and mouse (chromosome 15; 102,576,412–102,577,508 
bp; assembly mm9) CISTR-ACT were cloned in the Sfi-Hsp68LacZ reporter 
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